|
|
Vaccine Detail
|
AREPANRIX H1N1 |
| Vaccine Information |
- Vaccine Name: AREPANRIX H1N1
- Target Pathogen: Influenza virus
- Target Disease: Influenza (flu)
- Product Name: AS03-Adjuvanted H1N1 Pandemic Influenza Vaccine
- Tradename: AREPANRIX H1N1
- Manufacturer: GlaxoSmithKline Inc.
- Vaccine Ontology ID: VO_0001247
- Type: Inactivated or "killed" vaccine
- Status: Licensed
- Location Licensed: Canada
- Host Species for Licensed Use: Human
- Antigen: Split influenza virus, inactivated, containing antigen equivalent to: A/California/7/2009 (H1N1)v-like strain (X-179A) 3.75μg HA per 0.5mL dose (Health Canada DPD).
- Adjuvant:
- Immunization Route: Intramuscular injection (i.m.)
- Storage: Store at 2°C to 8°C (in a refrigerator).
- Approved Age for Licensed Use: Adults aged 18-60 years
|
| Host Response |
|
|
| References |
Health Canada DPD: Health Canada Drug Product Database [http://www.hc-sc.gc.ca/dhp-mps/prodpharma/databasdon/index-eng.php]
|
|
